These effects could counteract the excessive inflammation, fibrosis and cardiac and renal pathology associated with COVID‐19 as much of its pathology is associated with the dysregulation of the renin‐angiotensin system (RAS) from antagonization of angiotensin‐converting enzyme 2 (ACE2).40 Here, ACE2 is linked to COVID-19.